SCHEMBL10132370

SCHEMBL10132370

CC(C)(C)OC(=O)N1CCC[C@H]1Cc1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.50
▸ POLB P06746 1/20 0.49
▸ USP30 Q70CQ3 2/20 0.48
▸ UCHL1 P09936 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NR1H2 P55055 2/20 0.47
▸ NR1H3 Q13133 2/20 0.47
▸ GRM5 P41594 1/20 0.46
▸ F2 P00734 2/20 0.45
▸ HCRTR1 O43613 1/20 0.45
▸ HCRTR2 O43614 1/20 0.45
▸ NPSR1 Q6W5P4 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ DPP4 P27487 1/20 0.45
▸ DPP8 Q6V1X1 1/20 0.45
▸ DPP9 Q86TI2 1/20 0.45
▸ DPP7 Q9UHL4 1/20 0.45
▸ STS P08842 1/20 0.44
▸ LMNA P02545 3/20 0.44
▸ TSHR P16473 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990776 0.88 STS (0.48) ALDH1A1POLBNR1H2NR1H3NPSR1
SCHEMBL10132498 0.87 NR1H2 (0.48) ALDH1A1UCHL1NR1H2NR1H3HCRTR1
SCHEMBL14940097 0.86 NR1H2 (0.47) ALDH1A1USP30UCHL1NR1H2NR1H3
SCHEMBL10132273 0.86 GPR119 (0.49) UCHL1NR1H2NR1H3HCRTR1HCRTR2
SCHEMBL14940096 0.86 NR1H2 (0.47) ALDH1A1USP30UCHL1NR1H2NR1H3
SCHEMBL10132293 0.86 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2NR1H2NR1H3NPSR1
SCHEMBL698422 0.86 NR1H2 (0.54) NR1H2NR1H3DPP4STSMEN1
SCHEMBL27854990 0.86 NR1H2 (0.54) NR1H2NR1H3DPP4STSMEN1
SCHEMBL698218 0.86 NR1H2 (0.54) NR1H2NR1H3DPP4STSMEN1
SCHEMBL3640317 0.85 HRH3 (0.53) ALDH1A1USP30NR1H2NR1H3HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374794-B1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO CO LTD (JP) 2015-11-04 — — EP disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 — — US disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 — — US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 — — US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 — — US disclosed
EP-2374794-A1 CYCLIC AMINE COMPOUNDS Daiichi Sankyo Company, Limited (JP) 2011-10-12 — — EP disclosed
WO-2010074088-A1 CYCLIC AMINE COMPOUNDS 第一三共株式会社 (JP) 2010-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319468-A1 CYCLIC AMINE COMPOUNDS RYR2, CASR, RYR1 ALDH1A1 2584/4885POLB 3807/4885USP30 4326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback